3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Hematopoietic and Lymphatic System Neoplasm
7
Neoplasms
5
Lung Neoplasms
5
Malignant Solid Neoplasm
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Hematologic Neoplasms
3
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Depression
2
Colonic Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Adenocarcinoma, Follicular
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Interventions
Cyclophosphamide
30
Rituximab
26
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
15
Prednisone
13
Vincristine
11
Doxorubicin
10
obinutuzumab
9
Lenalidomide
9
Etoposide
8
Bendamustine Hydrochloride
8
venetoclax
7
pembrolizumab
7
glofitamab
6
X-Rays
6
Nuclear Medicine Department, Hospital
6
trametinib
5
ibrutinib
5
fludarabine phosphate
5
Tacrolimus
5
Gemcitabine
5
Dexamethasone
5
Crizotinib
5
copanlisib
4
acalabrutinib
4
Nivolumab
4
Mycophenolic Acid
4
Busulfan
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Interviews as Topic
×
90 days
×
Clear all
No trials found.